Henry DH - Search Results

1

Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.

Henry DH, Glaspy J, Harrup R, Mittelman M, Zhou A, Carraway HE, Bradley C, Saha G, Modelska K, Bartels P, Leong R, Yu KP. Henry DH, et al. Am J Hematol. 2022 Feb 1;97(2):174-184. doi: 10.1002/ajh.26397. Epub 2021 Nov 9. Am J Hematol. 2022. PMID: 34724251 Free article. Clinical Trial.

2

Retroviral diseases in hematology.

Spivak JL, Henry D, Glaspy J. Spivak JL, et al. Rev Invest Clin. 1994 Apr;Suppl:40-6. Rev Invest Clin. 1994. PMID: 7886307 Review. No abstract available.

3

Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.

Henry DH. Henry DH. Semin Hematol. 1993 Oct;30(4 Suppl 6):12-6. Semin Hematol. 1993. PMID: 8153671 Review.

4

Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.

Henry DH, Abels RI. Henry DH, et al. Semin Oncol. 1994 Apr;21(2 Suppl 3):21-8. Semin Oncol. 1994. PMID: 8202722 Clinical Trial.

5

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa.

Glaspy J, Henry D, Patel R, Tchekmedyian S, Applebaum S, Berdeaux D, Lloyd R, Berg R, Austin M, Rossi G; Darbepoetin Alfa 20010162 Study Group. Glaspy J, et al. Eur J Cancer. 2005 May;41(8):1140-9. doi: 10.1016/j.ejca.2005.01.021. Epub 2005 Apr 8. Eur J Cancer. 2005. PMID: 15911237 Clinical Trial.

6

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

Ludwig H, Crawford J, Osterborg A, Vansteenkiste J, Henry DH, Fleishman A, Bridges K, Glaspy JA. Ludwig H, et al. Among authors: henry dh. J Clin Oncol. 2009 Jun 10;27(17):2838-47. doi: 10.1200/JCO.2008.19.1130. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380447

7

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

Glaspy J, Crawford J, Vansteenkiste J, Henry D, Rao S, Bowers P, Berlin JA, Tomita D, Bridges K, Ludwig H. Glaspy J, et al. Br J Cancer. 2010 Jan 19;102(2):301-15. doi: 10.1038/sj.bjc.6605498. Epub 2010 Jan 5. Br J Cancer. 2010. PMID: 20051958 Free PMC article.

8

Parenteral iron therapy in cancer-associated anemia.

Henry DH. Henry DH. Hematology Am Soc Hematol Educ Program. 2010;2010:351-6. doi: 10.1182/asheducation-2010.1.351. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239818

9

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.

Henry DH, Dahl NV, Auerbach MA. Henry DH, et al. Am J Hematol. 2012 Mar;87(3):308-10. doi: 10.1002/ajh.22262. Epub 2012 Jan 20. Am J Hematol. 2012. PMID: 22262486 Free article.

10

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J. Vansteenkiste J, et al. Lung Cancer. 2012 Jun;76(3):478-85. doi: 10.1016/j.lungcan.2011.12.015. Epub 2012 Jan 25. Lung Cancer. 2012. PMID: 22277104 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page